Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection

Ulrike I. Mödder, Matthew M. Roforth, Kristy M. Nicks, James M. Peterson, Louise K. McCready, David G Monroe, Sundeep Khosla

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Studies on the pathogenesis of osteoporosis and other metabolic bone diseases would be greatly facilitated by the development of approaches to assess changes in gene expression in osteoblast/osteoprogenitor populations in vivo without the potentially confounding effects of in vitro culture and expansion of the cells. While positive selection to identify a progenitor population in human marrow can be used to select for cells capable of osteoblast differentiation, each of the markers that have been used to identify marrow mesenchymal populations (alkaline phosphatase [AP], Stro-1, CD29, CD49a, CD73, CD90, CD105, CD166, CD44, CD146 and CD271) may be expressed on distinct subsets of marrow mesenchymal cells. Thus, positive selection with one or more of these markers could exclude a possibly relevant cell population that may undergo important changes in various clinical conditions. In the present report, we describe the isolation and characterization of human osteoprogenitor cells obtained by depletion of bone marrow cells of all hematopoietic lineage/hematopoietic stem cells and endothelial/endothelial precursor cells (lin-/CD34/CD31). The yield of lin-/CD34/CD31 - cells from ~ 10 mL of bone marrow (~ 80 million mononuclear cells) was ~ 80,000 cells (0.1% of mononuclear cells). While not selected on the basis of expression for the mesenchymal marker, Stro-1, 68% of these cells were Stro-1+ Using linear whole transcriptome amplification followed by quantitative polymerase chain reaction (QPCR) analysis, we also demonstrated that, compared to lin - cells (which are already depleted of hematopoietic cells), lin-/CD34/31 - cells expressed markedly lower mRNA levels for the endothelial/hematopoietic markers, CD34, CD31, CD45, and CD133. Lin-/CD34/31 - cells were also enriched for the expression of mesenchymal/osteoblastic markers, with a further increase in runx2, osterix, and AP mRNA expression following in vitro culture under osteogenic conditions. Importantly, lin-/CD34/31 - cells contained virtually all of the mineralizing cells in human marrow: while these cells displayed robust calcium deposition in vitro, lin-/CD34/31 + cells demonstrated little or no mineralization when cultured under identical osteogenic conditions. Lin-/CD34/31 - cells thus represent a human bone marrow population highly enriched for mesenchymal/osteoblast progenitor cells that can be analyzed without in vitro culture in various metabolic bone disorders, including osteoporosis and aging.

Original languageEnglish (US)
Pages (from-to)804-810
Number of pages7
JournalBone
Volume50
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Mesenchymal Stromal Cells
Bone Marrow
Osteoblasts
Population
Osteoporosis
Alkaline Phosphatase
Integrin alpha1beta1
Messenger RNA
Metabolic Bone Diseases
Differentiation Antigens
Hematopoietic Stem Cells
Transcriptome
Bone Marrow Cells

Keywords

  • Bone biopsy
  • Bone marrow
  • Metabolic bone disease
  • Osteoblast
  • Osteoporosis

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology

Cite this

Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection. / Mödder, Ulrike I.; Roforth, Matthew M.; Nicks, Kristy M.; Peterson, James M.; McCready, Louise K.; Monroe, David G; Khosla, Sundeep.

In: Bone, Vol. 50, No. 3, 03.2012, p. 804-810.

Research output: Contribution to journalArticle

Mödder, Ulrike I. ; Roforth, Matthew M. ; Nicks, Kristy M. ; Peterson, James M. ; McCready, Louise K. ; Monroe, David G ; Khosla, Sundeep. / Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection. In: Bone. 2012 ; Vol. 50, No. 3. pp. 804-810.
@article{d93bfe0e65144b6a948241c86d82a6a6,
title = "Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection",
abstract = "Studies on the pathogenesis of osteoporosis and other metabolic bone diseases would be greatly facilitated by the development of approaches to assess changes in gene expression in osteoblast/osteoprogenitor populations in vivo without the potentially confounding effects of in vitro culture and expansion of the cells. While positive selection to identify a progenitor population in human marrow can be used to select for cells capable of osteoblast differentiation, each of the markers that have been used to identify marrow mesenchymal populations (alkaline phosphatase [AP], Stro-1, CD29, CD49a, CD73, CD90, CD105, CD166, CD44, CD146 and CD271) may be expressed on distinct subsets of marrow mesenchymal cells. Thus, positive selection with one or more of these markers could exclude a possibly relevant cell population that may undergo important changes in various clinical conditions. In the present report, we describe the isolation and characterization of human osteoprogenitor cells obtained by depletion of bone marrow cells of all hematopoietic lineage/hematopoietic stem cells and endothelial/endothelial precursor cells (lin-/CD34/CD31). The yield of lin-/CD34/CD31 - cells from ~ 10 mL of bone marrow (~ 80 million mononuclear cells) was ~ 80,000 cells (0.1{\%} of mononuclear cells). While not selected on the basis of expression for the mesenchymal marker, Stro-1, 68{\%} of these cells were Stro-1+ Using linear whole transcriptome amplification followed by quantitative polymerase chain reaction (QPCR) analysis, we also demonstrated that, compared to lin - cells (which are already depleted of hematopoietic cells), lin-/CD34/31 - cells expressed markedly lower mRNA levels for the endothelial/hematopoietic markers, CD34, CD31, CD45, and CD133. Lin-/CD34/31 - cells were also enriched for the expression of mesenchymal/osteoblastic markers, with a further increase in runx2, osterix, and AP mRNA expression following in vitro culture under osteogenic conditions. Importantly, lin-/CD34/31 - cells contained virtually all of the mineralizing cells in human marrow: while these cells displayed robust calcium deposition in vitro, lin-/CD34/31 + cells demonstrated little or no mineralization when cultured under identical osteogenic conditions. Lin-/CD34/31 - cells thus represent a human bone marrow population highly enriched for mesenchymal/osteoblast progenitor cells that can be analyzed without in vitro culture in various metabolic bone disorders, including osteoporosis and aging.",
keywords = "Bone biopsy, Bone marrow, Metabolic bone disease, Osteoblast, Osteoporosis",
author = "M{\"o}dder, {Ulrike I.} and Roforth, {Matthew M.} and Nicks, {Kristy M.} and Peterson, {James M.} and McCready, {Louise K.} and Monroe, {David G} and Sundeep Khosla",
year = "2012",
month = "3",
doi = "10.1016/j.bone.2011.12.014",
language = "English (US)",
volume = "50",
pages = "804--810",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selection

AU - Mödder, Ulrike I.

AU - Roforth, Matthew M.

AU - Nicks, Kristy M.

AU - Peterson, James M.

AU - McCready, Louise K.

AU - Monroe, David G

AU - Khosla, Sundeep

PY - 2012/3

Y1 - 2012/3

N2 - Studies on the pathogenesis of osteoporosis and other metabolic bone diseases would be greatly facilitated by the development of approaches to assess changes in gene expression in osteoblast/osteoprogenitor populations in vivo without the potentially confounding effects of in vitro culture and expansion of the cells. While positive selection to identify a progenitor population in human marrow can be used to select for cells capable of osteoblast differentiation, each of the markers that have been used to identify marrow mesenchymal populations (alkaline phosphatase [AP], Stro-1, CD29, CD49a, CD73, CD90, CD105, CD166, CD44, CD146 and CD271) may be expressed on distinct subsets of marrow mesenchymal cells. Thus, positive selection with one or more of these markers could exclude a possibly relevant cell population that may undergo important changes in various clinical conditions. In the present report, we describe the isolation and characterization of human osteoprogenitor cells obtained by depletion of bone marrow cells of all hematopoietic lineage/hematopoietic stem cells and endothelial/endothelial precursor cells (lin-/CD34/CD31). The yield of lin-/CD34/CD31 - cells from ~ 10 mL of bone marrow (~ 80 million mononuclear cells) was ~ 80,000 cells (0.1% of mononuclear cells). While not selected on the basis of expression for the mesenchymal marker, Stro-1, 68% of these cells were Stro-1+ Using linear whole transcriptome amplification followed by quantitative polymerase chain reaction (QPCR) analysis, we also demonstrated that, compared to lin - cells (which are already depleted of hematopoietic cells), lin-/CD34/31 - cells expressed markedly lower mRNA levels for the endothelial/hematopoietic markers, CD34, CD31, CD45, and CD133. Lin-/CD34/31 - cells were also enriched for the expression of mesenchymal/osteoblastic markers, with a further increase in runx2, osterix, and AP mRNA expression following in vitro culture under osteogenic conditions. Importantly, lin-/CD34/31 - cells contained virtually all of the mineralizing cells in human marrow: while these cells displayed robust calcium deposition in vitro, lin-/CD34/31 + cells demonstrated little or no mineralization when cultured under identical osteogenic conditions. Lin-/CD34/31 - cells thus represent a human bone marrow population highly enriched for mesenchymal/osteoblast progenitor cells that can be analyzed without in vitro culture in various metabolic bone disorders, including osteoporosis and aging.

AB - Studies on the pathogenesis of osteoporosis and other metabolic bone diseases would be greatly facilitated by the development of approaches to assess changes in gene expression in osteoblast/osteoprogenitor populations in vivo without the potentially confounding effects of in vitro culture and expansion of the cells. While positive selection to identify a progenitor population in human marrow can be used to select for cells capable of osteoblast differentiation, each of the markers that have been used to identify marrow mesenchymal populations (alkaline phosphatase [AP], Stro-1, CD29, CD49a, CD73, CD90, CD105, CD166, CD44, CD146 and CD271) may be expressed on distinct subsets of marrow mesenchymal cells. Thus, positive selection with one or more of these markers could exclude a possibly relevant cell population that may undergo important changes in various clinical conditions. In the present report, we describe the isolation and characterization of human osteoprogenitor cells obtained by depletion of bone marrow cells of all hematopoietic lineage/hematopoietic stem cells and endothelial/endothelial precursor cells (lin-/CD34/CD31). The yield of lin-/CD34/CD31 - cells from ~ 10 mL of bone marrow (~ 80 million mononuclear cells) was ~ 80,000 cells (0.1% of mononuclear cells). While not selected on the basis of expression for the mesenchymal marker, Stro-1, 68% of these cells were Stro-1+ Using linear whole transcriptome amplification followed by quantitative polymerase chain reaction (QPCR) analysis, we also demonstrated that, compared to lin - cells (which are already depleted of hematopoietic cells), lin-/CD34/31 - cells expressed markedly lower mRNA levels for the endothelial/hematopoietic markers, CD34, CD31, CD45, and CD133. Lin-/CD34/31 - cells were also enriched for the expression of mesenchymal/osteoblastic markers, with a further increase in runx2, osterix, and AP mRNA expression following in vitro culture under osteogenic conditions. Importantly, lin-/CD34/31 - cells contained virtually all of the mineralizing cells in human marrow: while these cells displayed robust calcium deposition in vitro, lin-/CD34/31 + cells demonstrated little or no mineralization when cultured under identical osteogenic conditions. Lin-/CD34/31 - cells thus represent a human bone marrow population highly enriched for mesenchymal/osteoblast progenitor cells that can be analyzed without in vitro culture in various metabolic bone disorders, including osteoporosis and aging.

KW - Bone biopsy

KW - Bone marrow

KW - Metabolic bone disease

KW - Osteoblast

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84856974708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856974708&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2011.12.014

DO - 10.1016/j.bone.2011.12.014

M3 - Article

C2 - 22226689

AN - SCOPUS:84856974708

VL - 50

SP - 804

EP - 810

JO - Bone

JF - Bone

SN - 8756-3282

IS - 3

ER -